Allogeneic Donor Derived Lmp Specific Cytotoxic T-Lymphocyte
Severe Chronic Active EBV (SCAEBV)
Baylor College of MedicineCell therapyPhase 1Dormant
C
32/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 17/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Severe Chronic Active EBV (SCAEBV) cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Mabel Ctls Baylor College of Medicine | Phase 1 | CC |
Fludarabine Baylor College of Medicine | Phase 1 | CC |
Cyclophosphamide Baylor College of Medicine | Phase 1 | CC |
Same molecule, other indications
Allogeneic Donor Derived Lmp Specific Cytotoxic T-Lymphocyte is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →